1h
Zacks Small Cap Research on MSNDWTX: Interim Data for Phase 2b Trial in 4Q25…DWTX READ THE FULL DWTX RESEARCH REPORT Business Update First Patient Dosed in Phase 2b Trial of Halneuron® On March 18, 2025 ...
2h
Zacks Investment Research on MSNBayer's Vividion Initiates Dosing in Early-Stage Cancer StudyBayer’s BAYRY wholly owned and independently operated subsidiary, Vividion Therapeutics, Inc, announced that the first ...
The Trump administration this week decimated HIV prevention programs across government health agencies after terminating ...
University of Kentucky Markey Cancer Center researchers presented promising results from an early-stage clinical trial ...
The Trump administration's cuts to the National Institutes of Health has some worried about stalls in research and medicine.
Research reveals how specific sleep stages protect brain vulnerable to Alzheimer's, offering hope through simple lifestyle ...
Tourmaline Bio's Pacibekitug shows promise in IL-6 targeting for autoimmune diseases. Learn about its potential and ongoing trials. Read why TRML is a hold.
Spending lower proportions of time in two deep sleep stages — including REM sleep — may be linked to volume changes in ...
Global development program for JNJ-1900 (NBTXR3) proceeding as planned, with opportunity to address one of the largest untapped markets in ...
When Dr. Filippo Milano left his home in Italy to study medicine in Seattle in 2008, it was supposed to be for six months, ...
After several on-again, off-again tariff threats, U.S. President Donald Trump is scheduled later today to announce what is expected to be country-by-country tariffs in an effort to address U.S. trade ...
The review article titled"Current insights and future directions in Peyronie's disease management: A narrative review", was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results